News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
New Automated Tool Monitors Clinical Trial Reporting
Diana Kwon | Feb 22, 2018
The watchdog website FDAAA TrialsTracker names and shames human studies that breach the FDA’s requirements for reporting results.
CDC: Flu Vaccine 36 Percent Effective So Far
Catherine Offord | Feb 16, 2018
The vaccine shows better-than-expected effectiveness against the most common and most virulent strain of influenza in children under 9 years old.
First Blood Test for Concussion Approved by FDA
Kerry Grens | Feb 16, 2018
The diagnostic measures two proteins indicative of brain injury.
Proposed Federal Budget Slashes Funds to EPA, CDC
Diana Kwon | Feb 13, 2018
Funds for the NIH and NSF would stay flat, while some agencies, including the FDA and NASA, would see increases.
FDA Declares Kratom an Opioid. We’re Here to Explain What It Does.
Jim Daley | Feb 7, 2018
speaks with a clinical toxicologist to discuss how the supplement acts in the brain and what the agency's declaration means for research.
Biohacker Injects DIY Herpes Vaccine on Facebook Live
Shawna Williams | Feb 5, 2018
The stunt, performed at a biohacking conference, was purportedly part of a two-subject trial of the genetically modified vaccine.
Gilead’s CAR T-Cell Therapy Administered to Just Five Patients in Two Months
Catherine Offord | Dec 17, 2017
More than 200 people are on waiting lists for the $373,000 treatment as hospitals try to work around problems with insurers.
Foundation Medicine’s Cancer Gene Test Gains FDA and CMS Approval
Diana Kwon | Dec 1, 2017
The Centers for Medicare and Medicaid Services propose covering the test with Medicare.
The Rising Research Profile of 23andMe
Catherine Offord | Nov 30, 2017
An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.
FDA Approves Second CAR T-Cell Therapy
Ashley P. Taylor | Oct 19, 2017
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas.